Ubs Group Ag Aspira Women'S Health Inc. Transaction History

Ubs Group Ag

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 08, 2023	BUY	$0.3 - $0.41 $1,715 - $2,344	5,718 New	5,718 $1,000
Q2 2022 Aug 10, 2022	SELL	$0.4 - $1.09 $1,401 - $3,819	-3,504 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$0.88 - $1.81 $21,673 - $44,578	-24,629 Reduced 87.54%	3,504 $4,000
Q4 2021 Feb 14, 2022	BUY	$1.63 - $3.43 $45,856 - $96,496	28,133 New	28,133 $50,000
Q3 2021 Nov 15, 2021	SELL	$3.19 - $5.48 $618 - $1,063	-194 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$4.78 - $6.84 $104,309 - $149,262	-21,822 Reduced 99.12%	194 $1,000
Q1 2021 May 12, 2021	BUY	$5.9 - $9.13 $34,579 - $53,510	5,861 Added 36.28%	22,016 $149,000
Q4 2020 Feb 11, 2021	BUY	$3.0 - $6.71 $45,408 - $101,562	15,136 Added 1485.38%	16,155 $108,000
Q3 2020 Nov 12, 2020	SELL	$2.54 - $4.56 $9,453 - $16,972	-3,722 Reduced 78.51%	1,019 $3,000
Q2 2020 Jul 31, 2020	BUY	$0.78 - $5.25 $3,697 - $24,890	4,741 New	4,741 $18,000

431K

Ticker AWH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 124,296,000
Market Cap $123M
Description
Aspira Women's Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company provides OVA1, OVERA, and OVA1plus to detect risk of ovarian malignancy in women with adnexal masses. It also offers ASPiRA GenetiX, a genetic test for the risk of gyneco...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.